Seeking Alpha

Three biotech IPOs begin trading

  • The hot offering of the day following yesterday's near-triple in Dicerna Pharmaceuticals (DRNA) is Ultragenyx Pharmaceutical (RARE), which raised $121M after pricing its IPO at $21 each vs. an expected range of $14-$17. The company also upsized the offering amount by 1M shares to 5.8M.
  • Cara Therapeutics (CARA) raised $55M after selling 5M shares at the low end of the expected $11-$13 range.
  • Trevena (TRVN) - which two months ago postponed its offering due to market conditions - raised $64.75M after pricing its IPO at $7 per share.
Comments (1)
  • misterbsw
    , contributor
    Comment (1) | Send Message
    retired pharmacist. Like to trade options. Long term holding for me is holding until 3:30 PM
    31 Jan, 11:23 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: